<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="10608">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00643006</url>
  </required_header>
  <id_info>
    <org_study_id>GAU2</org_study_id>
    <nct_id>NCT00643006</nct_id>
  </id_info>
  <brief_title>Physical Exercise and Its Impact on Signs of Inflammation in Fibromyalgia</brief_title>
  <official_title>Physical Exercise and Its Impact on Signs of Inflammation in Women With Fibromyalgia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Göteborg University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sahlgren´s University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Västra Götalands Forskningsfond</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Reumatikerförbundet</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Göteborg University</source>
  <oversight_info>
    <authority>Sweden: Regional Ethical Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to compare low-intensive and high-intensive physical exercise and its impact
      on physical function, pain and signs of inflammation.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2008</start_date>
  <completion_date type="Actual">June 2009</completion_date>
  <primary_completion_date type="Actual">May 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Six-minute Walk Test</measure>
    <time_frame>15 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Patient is instructed to walk as fast as she can. The distance covered during 6 minutes is documented.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of Pain Level From Baseline.</measure>
    <time_frame>15 weeks</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Pain was measured by The Fibromyalgia Impact Questionnaire (FIQ) subscale for Pain, which is a self-rated pain on visual analogue scale, 0-100 mm. The higher value, the worse pain.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">67</enrollment>
  <condition>Exercise Therapy</condition>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>A. High intensive exercise</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>High intensive exercise</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B. Low-intensive exercise</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Low-to-moderate intensive supervised walks</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Physical exercise</intervention_name>
    <description>Supervised walks with poles twice a week at moderate-high intensity</description>
    <arm_group_label>A. High intensive exercise</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Active comparator: low intensive exercise</intervention_name>
    <description>Supervised walks once a week at low-intensity.</description>
    <arm_group_label>B. Low-intensive exercise</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women with Fibromyalgia, interested in exercise twice a week

        Exclusion Criteria:

          -  Other severe diseases
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kaisa E Mannerkorpi, Ass prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Göteborg University, Dept of Rheumatology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Alingsås Primary Health Care</name>
      <address>
        <city>Alingsås</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sahlgrenska University Hospital, Dept of Physical Therapy</name>
      <address>
        <city>Göteborg</city>
        <zip>41345</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Uddevalla Primary Health Care</name>
      <address>
        <city>Uddevalla</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>September 2012</verification_date>
  <lastchanged_date>September 28, 2012</lastchanged_date>
  <firstreceived_date>March 19, 2008</firstreceived_date>
  <firstreceived_results_date>May 3, 2012</firstreceived_results_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Fibromyalgia</keyword>
  <keyword>Physical activity</keyword>
  <keyword>Function</keyword>
  <keyword>Pain</keyword>
  <keyword>Exercise</keyword>
  <keyword>Inflammation</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Fibromyalgia</mesh_term>
    <mesh_term>Inflammation</mesh_term>
    <mesh_term>Myofascial Pain Syndromes</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>A. High Intensive Exercise</title>
          <description>High intensive exercise by means of Nordic walking twice a week for 45 minutes during 15 weeks</description>
        </group>
        <group group_id="P2">
          <title>B. Low-intensive Exercise</title>
          <description>Low-to-moderate intensive supervised walks twice a week for 45 minutes during 15 weeks</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="34"/>
                <participants group_id="P2" count="33"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="29"/>
                <participants group_id="P2" count="29"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>A. High Intensive Exercise</title>
          <description>High intensive exercise by means of Nordic walking twice a week for 45 minutes during 15 weeks</description>
        </group>
        <group group_id="B2">
          <title>B. Low-intensive Exercise</title>
          <description>Low-to-moderate intensive supervised walks twice a week for 45 minutes during 15 weeks</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="34"/>
                <measurement group_id="B2" value="33"/>
                <measurement group_id="B3" value="67"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>&lt;=18 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Between 18 and 65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="34"/>
                <measurement group_id="B2" value="33"/>
                <measurement group_id="B3" value="67"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>&gt;=65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="48" spread="7.8"/>
                <measurement group_id="B2" value="50" spread="7.6"/>
                <measurement group_id="B3" value="49" spread="7.7"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="34"/>
                <measurement group_id="B2" value="33"/>
                <measurement group_id="B3" value="67"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Sweden</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="34"/>
                <measurement group_id="B2" value="33"/>
                <measurement group_id="B3" value="67"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Six-minute Walk Test</title>
        <description>Patient is instructed to walk as fast as she can. The distance covered during 6 minutes is documented.</description>
        <time_frame>15 weeks</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Arm A. Exercise</title>
            <description>The intervention group participated in Nordic walking</description>
          </group>
          <group group_id="O2">
            <title>Arm B. Active Comparator</title>
            <description>The active comparison group participated in low-intensive walks.</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="29"/>
                  <measurement group_id="O2" value="29"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Six-minute Walk Test</title>
            <description>Patient is instructed to walk as fast as she can. The distance covered during 6 minutes is documented.</description>
            <units>meter</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="37.7" spread="41.8"/>
                  <measurement group_id="O2" value="8.6" spread="42.2"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change of Pain Level From Baseline.</title>
        <description>Pain was measured by The Fibromyalgia Impact Questionnaire (FIQ) subscale for Pain, which is a self-rated pain on visual analogue scale, 0-100 mm. The higher value, the worse pain.</description>
        <time_frame>15 weeks</time_frame>
        <safety_issue>Yes</safety_issue>
        <population>Patients attending at post-test</population>
        <group_list>
          <group group_id="O1">
            <title>A. High Intensive Exercise</title>
            <description>High intensive exercise by means of Nordic walking twice a week for 45 minutes during 15 weeks</description>
          </group>
          <group group_id="O2">
            <title>B. Low-intensive Exercise</title>
            <description>Low-to-moderate intensive supervised walks twice a week for 45 minutes during 15 weeks</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="29"/>
                  <measurement group_id="O2" value="29"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Change of Pain Level From Baseline.</title>
            <description>Pain was measured by The Fibromyalgia Impact Questionnaire (FIQ) subscale for Pain, which is a self-rated pain on visual analogue scale, 0-100 mm. The higher value, the worse pain.</description>
            <units>mm</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="-4.0" spread="14.5"/>
                  <measurement group_id="O2" value="-5.3" spread="16.3"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>A. High Intensive Exercise</title>
          <description>High intensive exercise by means of Nordic walking twice a week for 45 minutes during 15 weeks</description>
        </group>
        <group group_id="E2">
          <title>B. Low-intensive Exercise</title>
          <description>Low-to-moderate intensive supervised walks twice a week for 45 minutes during 15 weeks</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>3</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. K Mannerkorpi</name_or_title>
      <organization>Gothenburg University</organization>
      <phone>046-31-24220</phone>
      <email>kaisa.mannerkorpi@rheuma.gu.se</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
